Trinity Biotech plc Sponsored ADR (TRIB)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
8. 03
+0.1
+1.261%
$
138.82M Market Cap
- P/E Ratio
- Div Yield
28,600 Volume
0 Eps
$ 7.93
Previous Close 
Want to track TRIB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Trinity Biotech plc Sponsored ADR (TRIB) Statistics
Valuation metrics
Market Cap 138.82M
Enterprise value 295.46M
Trailing P/E (ttm) -0.17
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 4.48
Price/Book (mrq) -0.07
Enterprise Value/Revenue 8.14
Enterprise Value/EBITDA -66.08
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 20.55K
Average volume (90 days) 23.17K
Price summary
52-Week low 0.31
52-Week high 14.17
Beta -
50-Day moving average 7.49
200-Day moving average 10.51
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Jul 2015
Ex-Dividend Date 5 Jun 2015
Last split factor 1:30
Last split Date 24 Jul 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.79%
Operating margin -0.18%
Operational effectiveness
Return on assets -0.27%
Return on equity 0.49%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 58.44
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -46.1
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.28
Total debt (mrq) -
Total Debt/Equity (mrq) -1.92
Current ratio (mrq) 0.25%
Book value per share (mrq) -115.93
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
